Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « advances »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
advancements < advances < advancing  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000028 (2020) Evan A. Choate [États-Unis] ; Gurjit S. Kaeley ; Jenny Brook [États-Unis] ; Roy D. Altman [États-Unis] ; John D. Fitzgerald [États-Unis] ; Astrid R. Floegel-Shetty [États-Unis] ; David A. Elashoff [États-Unis] ; Veena K. Ranganath [États-Unis]Ultrasound detects synovitis in replaced and other surgically operated joints in rheumatoid arthritis patients
000061 (2020) Ver Nica Cantarín-Extremera [Espagne] ; María Jiménez-Legido [Espagne] ; Anna Duat-Rodríguez [Espagne] ; Marta García-Fernández [Espagne] ; Nelmar Valentina Ortiz-Cabrera [Espagne] ; María Luz Ruiz-Falc Rojas [Espagne] ; Luis González-Gutiérrez-Solana [Espagne]Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients.
000079 (2020) Caterina Vacchi [Italie] ; Marco Sebastiani [Italie] ; Giulia Cassone [Italie] ; Stefania Cerri [Italie] ; Giovanni Della Casa [Italie] ; Carlo Salvarani [Italie] ; Andreina Manfredi [Italie]Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review
000200 (2020) Gregory M. Constantine [États-Unis] ; Michail S. Lionakis [États-Unis]Recent advances in understanding inherited deficiencies in immunity to infections
000201 (2020) Naomi Serling-Boyd [États-Unis] ; John H. StoneRecent advances in the diagnosis and management of giant cell arteritis.
000202 (2020) Giorgia Bucciol [Belgique] ; Isabelle Meyts [Belgique]Recent advances in primary immunodeficiency: from molecular diagnosis to treatment
000305 (2020) Susanne H. C. Baumeister [États-Unis] ; Benedetta Rambaldi [États-Unis, Italie] ; Roman M. Shapiro [États-Unis] ; Rizwan Romee [États-Unis]Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation
000311 (2020) Durga Prasanna Misra [Inde] ; Sakir Ahmed [Inde] ; Vikas Agarwal [Inde]Is biological therapy in systemic sclerosis the answer?
000368 (2020) Rosanna Dammacco [Italie] ; Giovanni Alessio [Italie] ; Ermete Giancipoli [Italie] ; Patrizia Leone [Italie] ; Anna Cirulli [Italie] ; Leonardo Resta [Italie] ; Angelo Vacca [Italie] ; Franco Dammacco [Italie]Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements
000392 (2020) S. P. Mollan [Royaume-Uni] ; K. Paemeleire [Belgique] ; J. Versijpt [Belgique] ; R. Luqmani ; A. J. Sinclair [Royaume-Uni]European Headache Federation recommendations for neurologists managing giant cell arteritis
000454 (2020) He Huang [République populaire de Chine] ; Heng-Wei Wu [République populaire de Chine] ; Yong-Xian Hu [République populaire de Chine]Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma
000455 (2020) Hao Wang [République populaire de Chine] ; Zheng Xiao [République populaire de Chine]Current Progress on Assessing the Prognosis for Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis
000500 (2020) Ricardo L. B. Costa ; Brian J. CzernieckiClinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond
000513 (2020) Florence A. Aeschlimann [France, Suisse] ; Marinka Twilt [Canada] ; Rae S. M. Yeung [Canada]Childhood-onset Takayasu Arteritis
000580 (2020) Jonghee Hong [Corée du Sud] ; Minji Bang [Corée du Sud]Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing
000591 (2020) Xian Zhang [République populaire de Chine] ; Jing-Jing Li [République populaire de Chine] ; Pei-Hua Lu [République populaire de Chine]Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia
000592 (2020) Jinxin Qi [République populaire de Chine, Canada] ; Chengchao Ding [République populaire de Chine] ; Xian Jiang [République populaire de Chine] ; Yong Gao [Canada, République populaire de Chine]Advances in Developing CAR T-Cell Therapy for HIV Cure
000593 (2020) Jingyu Wang [République populaire de Chine] ; Fang Shen [République populaire de Chine] ; Ying Yao [République populaire de Chine] ; Lin-Lin Wang [République populaire de Chine] ; Yongjian Zhu [République populaire de Chine] ; Jue Hu [République populaire de Chine]Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "advances" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "advances" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    advances
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021